Page 56 - JCBP-3-4

Journal of Clinical and
Basic Psychosomatics Emotion and blood pressure variability

face perception task. It is possible that altered physiological Availability of data
processes (e.g., HR, HR variability, and eye movement)
contribute to ER and long-term BP effects, warranting The raw data supporting the conclusions of this article will
investigation in future studies. Fourth, information about be made available by the authors on request.
overall health status and family history was not collected. References
These variables may influence BP measures and CVD risk
and, therefore, should be included in future studies with 1. Timmis A, Vardas P, Townsend N, et al. European Society
larger samples. Finally, gender and race are important of Cardiology: Cardiovascular disease statistics 2021. Eur
factors influencing health indicators, life stressors, and Heart J. 2022;43(8):716-799.
ER. 64,65 These variables should also be analyzed in future doi: 10.1093/eurheartj/ehab892
studies. 2. Laslett LJ, Alagona, P, Clark BA 3 , et al. The worldwide
rd
5. Conclusion environment of cardiovascular disease: Prevalence,
diagnosis, therapy, and policy issues: A report from the
In the present study, we found that individual differences American College of Cardiology. J Am Coll Cardiol.
in the habitual use of ER strategies influence BP, potentially 2012;60(S25):S1-S49.
explaining the negative effect of affective disorders on doi: 10.1016/j.jacc.2012.11.002
cardiovascular health. 66,67 To the best of our knowledge, this 3. Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular
study is among the first to document the differential effects disease mortality, incidence, and mortality-to-incidence
of expressive suppression and cognitive reappraisal on ratio: Results from global burden of disease study 2017.
BPV. These findings offer important practical implications BMC Public Health. 2021;21:401.
for CVD prevention.
doi: 10.1186/s12889-021-10429-0
Acknowledgments 4. Callow AD. Cardiovascular disease 2005--the global picture.

None. Vasc Pharmacol. 2006;45(5):302-307.
doi: 10.1016/j.vph.2006.08.010
Funding
5. Vaduganathan M, Mensah GA, Turco JV, Fuster V,
None. Roth GA. The global burden of cardiovascular diseases
and risk: A compass for future health. J Am Coll Cardiol.
Conflict of interest 2022;80(25):2361-2371.
The authors declare that they have no competing interests. doi: 10.1016/j.jacc.2022.11.005

Author contributions 6. Barinas-Mitchell E, Yang X, Matthews KA, et al. Childhood-
onset depression and arterial stiffness in young adulthood.
Conceptualization: Xiao Yang, Fang Fang J Psychosom Res. 2021;148:110551.
Formal analysis: Xiao Yang, Catalina Roldan, Fang Fang doi: 10.1016/j.jpsychores.2021.110551
Investigation: Xiao Yang, Catalina Roldan, Cathryn
Gallagher, Katie Heberlein 7. Goessl VC, Curtiss JE, Hofmann SG. The effect of heart
Methodology: Xiao Yang, Catalina Roldan rate variability biofeedback training on stress and anxiety:
A meta-analysis. Psychol Med. 2017;47(15):2578-2586.
Writing – original draft: Xiao Yang
Writing – review & editing: Xiao Yang, Fang Fang doi: 10.1017/S0033291717001003
8. Brown L, Rando AA, Eichel K, et al. The effects of mindfulness
Ethics approval and consent to participate and meditation on vagally mediated heart rate variability:
This study was conducted in accordance with the Declaration A meta-analysis. Psychosom Med. 2021;83(6):631-640.
of Helsinki and was approved by the Old Dominion doi: 10.1097/PSY.0000000000000900
University Sciences Human Subjects Review Committee 9. Schiffrin EL. Beyond blood pressure: The endothelium
(protocol code 1837201–8). All human subjects provided and atherosclerosis progression. Am J Hypertens.
informed consent before participation in the study. 2002;15(S5):115S-122S.

Consent for publication doi: 10.1016/s0895-7061(02)03006-6
Both verbal and written consent were obtained from all 10. Ziegler MG. Atherosclerosis and blood pressure variability.
human subjects, and permission was obtained from each Hypertension. 2018;71(3):403-405.
of the subjects to publish their data. doi: 10.1161/HYPERTENSIONAHA.117.10481

Volume 3 Issue 4 (2025) 50 doi: 10.36922/jcbp.8134